Oncology 101

Triple-Negative Breast Cancer

Debra L. Winkeljohn

breast cancer, estrogen
CJON 2008, 12(6), 861-863. DOI: 10.1188/08.CJON.861-863

Jump to a section


    American Cancer Society. (2008). Breast cancer facts. Retrieved June 15, 2008, from http://www.cancer.org/docroot/MED/content/MED_1_1_Most_Requested_Graphs_and_figures-2008.asp
    Bauer, K. R., Brown, M., Cress, R. D., Parise, C. A., & Caggiano, V. (2007). Descriptive analysis of estrogen receptor(ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so called triple negative phenotype. Cancer, 109(9), 1721-1728.
    Haffty, B. G., Yang, Q., Reiss, M., Kearney, T., Higgins, S. A., Weidhaas, J., et al. (2006). Locoregional relapse and distant metastasis in conservatively managed triple negative early stage breast cancer. Journal of Clinical Oncology, 24(36), 5652-5657.
    Keam, B., Im, S., Kim, H., Oh, D., Kim, J. H., Lee, S., et al. (2007). Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: Paradoxical features of the triple negative breast cancer. Retrieved June 27, 2008, from http://www.biomedcentral.com/1471-2407/7/203prepub
    Liedtke, C., Mazouni, C., Hess, K. R., Andre, F., Tordai, A., Mejia, J. A., et al. (2008). Response to neoadjuvant therapy and long-term survival in patients with triple negative breast cancer. Journal of Clinical Oncology, 26(8), 1275-1281.
    National Comprehensive Cancer Network. (2008). NCCN guidelines. Guidelines for treatment of cancer by site: Breast cancer. Retrieved July 14, 2008, from http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
    National Institutes of Health. (2008a). Triple negative breast cancer trial (TNT). Retrieved November 3, 2008, from http://clinicaltrials.gov/ct2/show/NCT00532727
    National Institutes of Health. (2008b). Triple negative breast cancer trials. Retrieved November 3, 2008, from http://clinicaltrials.gov/ct2/results?term=triple+negative
    Reis-Filho, J. S., & Tutt, A. N. (2008). Triple negative tumours: A critical review. Histopathology, 52(1), 108-118.
    Reynolds, S. (2007). Triple negative breast cancer disproportionately affects African American and Hispanic women. Retrieved July 20, 2008, from http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_072407/page7
    Tuma, R. S. (2007). Race, low socioeconomic status, and triple negative breast cancer. Oncology Times, 28(11), 50-51.
    UpToDate.com. (2008) Adjuvant systemic therapy for hormone receptor positive early stage breast cancer in postmenopausal women. Retrieved August 1, 2008, from http://www.uptodate.com/online/content/topic.do?topicKey=breastcn/15843&selectedTitle=25~150&source=search_result